Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherBrowse by ChannelAbout the NetworkJoin the NetworkProductsSub-MenuProducts OverviewBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAbout UsContactSubscribeSupport
Book a Demo
Search
Close

FDA & FTC Issue Warning Letters Regarding Unsupported COVID-19 Claims

By Jason Howell, Jared Bryant & Tommy Tobin on March 23, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

The FDA and FTC recently issued joint warning letters to seven sellers of products that claimed to treat or prevent “Novel Coronavirus Disease 2019,” known as COVID-19.

According to FDA Commissioner Stephen Hahn, “The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health.”  FTC Chairman Joe Simons noted, “There already is a high level of anxiety over the potential spread of coronavirus.”

The products named in the warning letters included teas, essential oils, tinctures and colloidal silver.  Warning letters were sent to the following companies:

  • Vital Silver,
  • Quinessence Aromatherapy Ltd.,
  • Xephyr, LLC doing business as N-Ergetics,
  • GuruNanda, LLC,
  • Vivify Holistic Clinic,
  • Herbal Amy LLC, and
  • The Jim Bakker Show.

The companies receiving the warning letters were provided 48 hours to respond with specific actions taken to address the agencies’ concerns.

According to the FDA’s statement, there are currently no vaccines or drugs approved to treat or prevent COVID-19. The FDA and FTC noted that they will “continue to monitor social media, online marketplaces and incoming complaints to help ensure that the companies do not continue to sell fraudulent products under a different company name or on another website.”

In a February blog post, the FTC warned that scammers were following the COVID-19 headlines and cautioned that “scammers are taking advantage of fears surrounding the Coronavirus.”

FDA has set up a cross-agency task force to monitor for fraudulent products purporting to treat or prevent COVID-19.  The FDA has announced that more than three dozen of such products have been removed from major retailers and online marketplaces.

Takeaways:

  • Marketers should ensure that they have competent and reliable scientific evidence to support any COVID-19-related advertising and labeling claims about their products before such claims are made. Practically speaking, marshalling such evidence may be difficult at this time as much remains unknown about the virus responsible for COVID-19 and effective treatments for the disease.
  • Advertising that a product can prevent, mitigate, cure, or treat COVID-19 may result in the product being qualified as an unapproved new drug sold in violation of the Federal Food, Drug, & Cosmetic Act.
Photo of Jason Howell Jason Howell

Jason Howell serves as co-chair of the Advertising, Marketing & Promotions practice and as a member of the Trademark, Copyright & Media practice.

Read more about Jason HowellEmail
Photo of Jared Bryant Jared Bryant

Jared Bryant has experience helping brands, from startups to top Fortune 500 companies, to navigate complex state, federal, and local laws governing various marketing, advertising, promotions, consumer protection, copyright, trademark, and right-of-publicity legal issues.

Email
Photo of Tommy Tobin Tommy Tobin

Thomas Tobin’s practice focuses on complex commercial litigation and class action matters involving statutory, constitutional, and regulatory issues in a range of industries, including food and beverage, consumer packaged goods, and cannabis. In the food and beverage sector, Tommy has experience defending false…

Thomas Tobin’s practice focuses on complex commercial litigation and class action matters involving statutory, constitutional, and regulatory issues in a range of industries, including food and beverage, consumer packaged goods, and cannabis. In the food and beverage sector, Tommy has experience defending false advertising claims and consumer protection claims for well-known international corporations.

Read more about Tommy TobinEmail
Show more Show less
  • Posted in:
    Corporate & Commercial
  • Blog:
    Consumer Protection Review
  • Organization:
    Perkins Coie LLP
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • Resource Center
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center
  • Blogging 101

New to the Network

  • Through The Immigration Lens
  • Tennessee Insurance Litigation Blog
  • Claims & Sustains
  • New Jersey Restraining Order Lawyers
  • New Jersey Gun Lawyers
Copyright © 2025, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo